GRIFOLS SA INH. A EO-,25/ ES0171996087 /
| 2024-06-05 8:01:10 AM | Chg. -0.276 | Volume | Bid12:40:37 PM | Ask12:40:37 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 9.232EUR | -2.90% | - Turnover: - |
9.526Bid Size: 3,333 | 9.552Ask Size: 3,333 | 7.88 bill.EUR | - | 105.96 |
GlobeNewswire
04-18
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...
GlobeNewswire
04-04
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...
GlobeNewswire
2023-11-15
Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous ...
